Please login to the form below

Not currently logged in
Email:
Password:

David Paragamian joins Razorfish Health

He becomes managing director of the Publicis Health agency

Razorfish David ParagamianNew York healthcare agency Razorfish Health has appointed David Paragamian as its managing director.

In his new role, Paragamian will be responsible for overseeing the Publicis Health agency's North America business, including its New York and Philadelphia offices.

Publicis Health group president Matt McNally said: “Dave's deep experience on both the client and agency sides of healthcare communications make him the perfect leader to take Razorfish Health to the next level.”

Paragamian has held a number of senior leadership roles for industry and agency companies, including Johnson & Johnson and Roche, most recently having served as president of ApotheCom.

Prior to this, he was Havas Healthcare's partner and chief executive officer for its Latin America business, and president of global healthcare and advertising communications network Euro RSCG Life.

Paragamian said: “Razorfish Health's positioning as a unique health and wellness agency with the deepest digital roots, strong analytics and outstanding creative makes us a unique full-service partner to drive our clients' brands now and into the future.

“I'm delighted to join the Publicis Health family.”

6th July 2016

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Windrose Consulting Group

Founded in 2015, Windrose Consulting Group is a privately-held global strategy firm that partners with life science companies to maximize...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....